Cargando…

Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With De Novo Donor-Specific Antibodies

Chronic active antibody-mediated rejection (AMR) in renal transplantation is usually refractory to current conventional treatment with rituximab, plasmapheresis (PP), and intravenous immunoglobulins (IVIG). Splenic irradiation has been reported to be effective in the rescue of early severe acute AMR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Lan, Guo, Zhiliang, Sa, Rula, Guo, Hui, Li, Junhua, Chen, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083054/ https://www.ncbi.nlm.nih.gov/pubmed/33936098 http://dx.doi.org/10.3389/fimmu.2021.661614

Ejemplares similares

Case report: Daratumumab for treatment of refractory late or chronic active antibody-mediated rejection in renal allograft recipients with high levels of de novo donor-specific antibodies
por: Zhu, Lan, et al.
Publicado: (2023)

Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection
por: Park, Woo Yeong, et al.
Publicado: (2021)

Donor plasma mitochondrial DNA is associated with antibody-mediated rejection in renal allograft recipients
por: Han, Fei, et al.
Publicado: (2021)

Association of intraindividual tacrolimus variability with de novo donor-specific HLA antibody development and allograft rejection in pediatric kidney transplant recipients with low immunological risk
por: Baghai Arassi, Maral, et al.
Publicado: (2022)

Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients
por: Mayer, Katharina A., et al.
Publicado: (2021)

A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy
por: Guo, Zhiliang, et al.
Publicado: (2023)

Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients
por: Mühlbacher, Jakob, et al.
Publicado: (2020)

Early Eosinophilic Antibody-mediated Rejection in a Renal Allograft Recipient
por: Satish, H., et al.
Publicado: (2018)

Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2016)

Role of de novo DQ donor-specific antibody in antibody-mediated rejection in renal transplant recipient: A case study
por: Chowdhry, Mohit, et al.
Publicado: (2019)

Analysis of Sera of Recipients with Allograft Rejection Indicates That Keratin 1 Is the Target of Anti-Endothelial Antibodies
por: Guo, Xuli, et al.
Publicado: (2017)

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018)

Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection
por: Miyairi, Satoshi, et al.
Publicado: (2021)

Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts
por: Betjes, Michiel G. H., et al.
Publicado: (2020)

The therapeutic challenge of late antibody‐mediated kidney allograft rejection
por: Böhmig, Georg A., et al.
Publicado: (2019)

Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure
por: Parajuli, Sandesh, et al.
Publicado: (2019)

Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy
por: Kühne, Louisa, et al.
Publicado: (2017)

Role of anti-vimentin antibodies in allograft rejection
por: Rose, Marlene L
Publicado: (2013)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
por: Park, Borae Geum, et al.
Publicado: (2019)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients
por: Fernández Rivera, Constantino, et al.
Publicado: (2022)

Association between anti‐endothelial antigen antibodies and allograft rejection in kidney transplantation
por: Lee, Hyun Ji, et al.
Publicado: (2023)

Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
por: Fichtner, Alexander, et al.
Publicado: (2021)

Donor-But Not Recipient-Derived Cells Produce Collagen-1 in Chronically Rejected Cardiac Allografts
por: Balam, Saidou, et al.
Publicado: (2022)

Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection
por: Crespo, Marta, et al.
Publicado: (2021)

The Role of Complement Split-products as Biomarkers for Acute Antibody-mediated Rejection of Kidney Allografts
por: Abu Jawdeh, Bassam G., et al.
Publicado: (2022)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction
por: Chung, Byung Ha, et al.
Publicado: (2018)

Impact of Acute Rejection on Kidney Allograft Outcomes in Recipients on Rapid Steroid Withdrawal
por: Heilman, R. L., et al.
Publicado: (2011)

Belatacept Treatment of Recurrent Late-onset T Cell–mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient
por: Klintmalm, Göran B., et al.
Publicado: (2022)

THE ROLE OF HUMORAL ANTIBODY IN THE REJECTION OF PRIMARY RENAL ALLOGRAFTS IN SHEEP
por: Pedersen, Niels C., et al.
Publicado: (1974)

Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody
por: Suneja, Manish, et al.
Publicado: (2012)

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
por: Roux, Antoine, et al.
Publicado: (2017)

Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver–kidney transplant recipients
por: Yazawa, Masahiko, et al.
Publicado: (2019)

Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients
por: Mertens, Inge, et al.
Publicado: (2020)

Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
por: Nourié, Nicole, et al.
Publicado: (2022)

Shifts in Intestinal Metabolic Profile Among Kidney Transplantation Recipients with Antibody-Mediated Rejection
por: Wang, Junpeng, et al.
Publicado: (2023)

Local Graft Irradiation for Kidney Allograft Rejection: A Case Series and Review of the Literature
por: Fallahzadeh, Mohammad Kazem, et al.
Publicado: (2014)

Safety and efficacy of eculizumab for the prevention of antibody‐mediated rejection after deceased‐donor kidney transplantation in patients with preformed donor‐specific antibodies
por: Glotz, Denis, et al.
Publicado: (2019)

Antibody-Mediated Rejection in Kidney Transplantation: A Retrospective Study on the Impact of Donor-Specific Antibodies and on the Timing of Diagnosis
por: Reis Pereira, Pedro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lrudj4m1dqpp58rqfjgfrabkio